Skip to main content
Equibles

688621 · 北京阳光诺和药物研究股份有限公司 · Debt

Use 688621 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 688621.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
71.0000 CNY +0.0500 (+0.07%) At close · Sep 30
Rebalance outlook locked
Market Cap
7.95B CNY
Shares
112.00M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2026-06-30 CNY 31,546,351 Interim report filed 2026-08-29
Long-term borrowings 2026-06-30 CNY 38,400,000 Interim report filed 2026-08-29
Short-term borrowings 2026-06-30 CNY 580,081,531 Interim report filed 2026-08-29
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.